Article
Toric IOL outperforms comparable spherical lens in FDA trial
San Diego - The AcrySof Toric IOL (Alcon Laboratories, Fort Worth, TX) is outperforming a comparable spherical IOL in uncorrected visual acuity (UCVA) levels and the low level of residual astigmatism. The interim safety and efficacy results of the FDA clinical trial of the AcrySof Toric IOL were presented here at the annual meeting of the American Society of Cataract and Refractive Surgery.
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Related Videos
Related Content
